Reversal of Marrow Fibrosis Following Imatinib Mesylate Therapy in a Patient with Chronic Myelogenous Leukemia Who Was Refractory to Interferon-alpha.
10.5045/kjh.2005.40.2.124
- Author:
Yeon Seong KIM
1
;
Tae Hun KIM
;
Won Chul KIM
;
Youn Joo JEON
;
Uk Hyun KIL
;
Hae Kyung LEE
;
Yeong Sik KIM
;
Sang Young RHO
;
Seok Goo CHO
Author Information
1. Division of Hematology, Department of Internal Medicine, St. Mary's Hospital, College of Medicine, The Catholic University of Korea 62, Youido-dong, Youngdungpo-gu, Seoul, Korea. chosg@catholic.ac.kr
- Publication Type:Case Report
- Keywords:
Imatinib mesylate;
Chronic myelogenous leukemia;
Marrow fibrosis
- MeSH:
Bone Marrow*;
Fibrosis*;
Humans;
Interferon-alpha*;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*;
Mesylates*;
Imatinib Mesylate
- From:Korean Journal of Hematology
2005;40(2):124-128
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
No abstract available.
